MATERIAL FACT - Second Ordinary Tariff Revision of Sabesp

PR Newswire |

SAO PAOLO, /PRNewswire/ -- Companhia de Saneamento Básico do Estado de São Paulo – Sabesp ("Company" or "Sabesp"), pursuant to the provisions of Article 157, Paragraph 4 of Law No. 6.404/76 and the provisions of CVM Instruction No. 358/02, announces to its shareholders and to the market in general that today, , the Regulatory Agency for Sanitation and Energy of the State of São Paulo (ARSESP - Agência Reguladora de Saneamento e Energia do Estado de São Paulo), published the new timeline for the initial stage of Sabesp's Tariff Revision, as below:

ARSESP Resolution No. 725 - INITIAL SCHEDULE OF THE 2ND TARIFF REVIEW OF SABESP

Stage No.

Description

Start

End

5-A

Receipt of Sabesp's additional data (ARSESP Resolution n°722/2017)

5-B

Analysis of Sabesp's additional data


6



Development of the Initial Technical Note with Preliminary Tariff P0 and Average Weighted cost of Capital (WACC)


7

Opening of the Public Consultation and Public Hearing - Preliminary Tariff P0 and WACC

8

Analysis of the contributions received, development of the Final Technical Note and Detailed Report - Preliminary Tariff P0 and WACC


9

Approval of the Final Technical Note, Detailed Report and Publication of the Resolution with Preliminary Tariff P0


The full text of Resolution No. 725 is found on ARSESP's and Sabesp's website.

The Company will keep the market informed of further developments regarding this material fact.

IR Contacts:
Mario Arruda Sampaio – +55 (11) 3388-8664 (maasampaio@sabesp.com.br)
Angela Beatriz Airoldi – +55 (11) 3388-8793 (abairoldi@sabesp.com.br)

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/material-fact---second-ordinary-tariff-revision-of-sabesp-300461020.html

SOURCE Sabesp

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Trending Articles

  • No items found.

Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

Initial State

Initial State is an Internet of Things (IoT) data analytics & data management platform company. We turn sensor and event data into information that matters by making it easy to…

Trustify

Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…